Neil Greening

NIHR Post-Doctoral Fellow, Associate Professor (Clinical)/Honorary Consultant Physician

University of Leicester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Neil Greening is an NIHR Post-Doctoral Fellow and Associate Professor (Clinical) at the University of Leicester, UK. His research focuses on the health outcomes and rehabilitation of patients post-COVID-19, including studies on long-term effects in individuals with diabetes and the efficacy of exercise-based rehabilitation for long COVID. He is also involved in exploring digital interventions for chronic obstructive pulmonary disease (COPD) and the seasonal dynamics of COPD exacerbations. Dr. Greening's work contributes significantly to understanding the complex health challenges arising in the aftermath of the COVID-19 pandemic.

Articles (30)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (58)

Nazrul Islam

Associate Professor of Epidemiology and Medical Statistics

University of Southampton

UNITED KINGDOM

Neil Greening

Research Interests

Explore related searches

Contact this professor

About

Articles (30)

Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study

Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation

Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study

Response

Cognitive and psychiatric symptom trajectories 2–3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK

Cognitive and psychiatric symptom trajectories 2-3 years after hospital admission for COVID-19: a longitudinal, prospective cohort study in the UK.

One year health outcomes associated with systemic corticosteroids for COVID-19: a longitudinal cohort study

Post-pandemic seasonal dynamics of hospitalised COPD exacerbations and aetiologies in the COPD population

Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis

Changes in fatigue symptoms following an exercise-based rehabilitation programme for patients with long COVID.

Collaboration between explainable artificial intelligence and pulmonologists improves the accuracy of pulmonary function test interpretation

Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization.

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis

Long COVID research: an update from the PHOSP-COVID Scientific Summit.

Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study.

Dupilumab in type 2 airway inflammation-a step forward in targeted therapy for COPD.

British Thoracic Society Clinical Statement on pulmonary rehabilitation

Differences in hospital admissions for acute exacerbations of COPD during the COVID-19 pandemic stratified by stable state blood eosinophil count.

Resistance Training in Post-COVID Recovery: Rationale and Current Evidence.

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation.

Usability of Wearable Multiparameter Technology to Continuously Monitor Free-Living Vital Signs in People Living With Chronic Obstructive Pulmonary Disease: Prospective Observational Study

Association of gut-related metabolites with respiratory symptoms in COVID-19: A proof-of-concept study

Diagnosis of COVID-19 by exhaled breath analysis using gas chromatography–mass spectrometry

A systematic review of the diagnostic accuracy of volatile organic compounds in airway diseases and their relation to markers of type-2 inflammation

Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study

The variability of volatile organic compounds in the indoor air of clinical environments.

Randomised controlled trial to investigate the use of high-frequency airway oscillations as <b>t</b>raining to <b>i</b>mprove <b>d</b>yspno<b>e</b>a (TIDe) in COPD.

Longitudinal changes to quadriceps thickness demonstrate acute sarcopenia following admission to hospital for an exacerbation of chronic respiratory disease

The validity of shortened multiple-breath washout testing using sulfur hexafluoride in the assessment of patients with COPD.

Extrathoracic muscle wasting in exacerbations of COPD: no longer outside the region of interest

Collaborators (58)

Nazrul Islam

Sally Jane Singh

Amit Kulkarni

Felip Burgos

Felicity Evison

Jonathan Heeney

Mark Orme

Michael Marks

Kay Por Yip

Nazir I Lone

John R. Petrie

Neil Hanley

Jacob George

Hamish McAuley

Gemma Clunie

Nigel D. Hart

Mark Halling-Brown

Cherie Armour

Peter Hellyer

Paul Monks

Julie Whitney

Elizabeth Sage

John Busby

Jon Hazeldine

Huzaifa Adamali

Gerry McCann

Charlotte Bolton

Timothy Wallis

Michael Gibbons

Paul Dark

Eric Derom

Tao Dong

Rachel Upthegrove

Vicky Kamwa

Christopher Miller

Catherine Atkin

Michael Crooks

Keith M. Channon

Michael Steiner

Annemarie Docherty

Manish Pareek

Joanna Porter

Alex Horsley